Skip to main content

Romano-Ward syndrome vs Jervell–Lange-Nielsen syndrome

Romano-Ward syndrome vs Jervell–Lange-Nielsen syndrome

Romano-Ward syndrome vs Jervell–Lange-Nielsen syndrome

A Detailed Clinical Review of Congenital Long QT Syndromes

Congenital Long QT Syndromes (LQTS) are inherited cardiac channelopathies characterized by delayed ventricular repolarization, leading to QT interval prolongation on ECG and a high risk of malignant ventricular arrhythmias. Among these, Romano–Ward syndrome and Jervell–Lange-Nielsen (JLN) syndrome represent two classic but clinically distinct entities.



---


Overview of Congenital Long QT Syndrome


LQTS results from mutations in genes encoding cardiac ion channels, primarily potassium and sodium channels. The hallmark is QT prolongation, predisposing patients to polymorphic ventricular tachycardia, especially Torsades de Pointes, which may degenerate into ventricular fibrillation and cause sudden cardiac death.


Common clinical manifestations include:


Syncope (often exercise- or stress-related)


Seizure-like episodes


Sudden cardiac arrest, particularly in young individuals




---


Romano–Ward Syndrome


Romano–Ward syndrome is the most common form of congenital LQTS.


Genetics and Inheritance


Inheritance pattern: Autosomal dominant


Most commonly affected genes:


KCNQ1 (LQT1)


KCNH2 (LQT2)


SCN5A (LQT3)




A single pathogenic variant is sufficient to produce the phenotype, and family history is often positive for syncope or sudden death.


Pathophysiology


Mutations lead to reduced outward potassium currents or persistent inward sodium current, causing delayed ventricular repolarization and QT prolongation.


Clinical Presentation


Onset: Childhood or adolescence


Symptoms:


Syncope during exercise or emotional stress


Palpitations


Sudden collapse triggered by swimming, exertion, or sudden auditory stimuli (especially LQT2)




Hearing is normal, which is a key distinguishing feature from JLN syndrome.


ECG Features


Prolonged corrected QT interval (QTc)


Normal QRS morphology


T-wave abnormalities depending on genotype



Risk Profile


Moderate to high risk of Torsades de Pointes


Sudden cardiac death risk varies by genotype and treatment adherence



Management


First-line therapy: Non-selective Ξ²-blockers (e.g., nadolol, propranolol)


Avoidance of QT-prolonging drugs


ICD implantation in high-risk patients (recurrent syncope, cardiac arrest, or Ξ²-blocker failure)



Prognosis


With early diagnosis and appropriate therapy, prognosis is generally good, and many patients live normal lives.



---


Jervell–Lange-Nielsen Syndrome


JLN syndrome represents the most severe form of congenital LQTS.


Genetics and Inheritance


Inheritance pattern: Autosomal recessive


Genes involved:


KCNQ1


KCNE1




Both alleles must be affected, typically inherited from asymptomatic carrier parents.


Pathophysiology


These genes are crucial for potassium ion transport in both the heart and inner ear. Severe loss of potassium channel function leads to:


Profound QT prolongation


Sensorineural deafness due to impaired endolymph potassium recycling



Clinical Presentation


Onset: Infancy or early childhood


Symptoms:


Early recurrent syncope


Seizures misdiagnosed as epilepsy


Sudden cardiac arrest at a young age




Congenital bilateral sensorineural deafness is universal and diagnostic.


ECG Features


Markedly prolonged QTc


Frequent ventricular ectopy


High susceptibility to Torsades de Pointes even with minimal triggers



Risk Profile


Very high risk of malignant arrhythmias


One of the highest sudden cardiac death risks among inherited arrhythmia syndromes



Management


Aggressive treatment required:


High-dose Ξ²-blockers


Early ICD implantation


Left cardiac sympathetic denervation in refractory cases



Multidisciplinary care including cardiology and audiology



Prognosis


Without early diagnosis and intervention, mortality is high in childhood. Early recognition dramatically improves survival.



---


Key Differences Between Romano–Ward and JLN Syndromes


Feature Romano–Ward Jervell–Lange-Nielsen


Inheritance Autosomal dominant Autosomal recessive

Hearing Normal Congenital deafness

QT prolongation Moderate to severe Markedly severe

Age of onset Childhood / adolescence Infancy

Sudden death risk Moderate–high Very high

Severity Milder LQTS phenotype Most severe LQTS




---


Clinical Importance of Differentiation


Correct differentiation between Romano–Ward and JLN syndromes is critical because:


Risk stratification differs significantly


Management intensity varies


Family screening and genetic counseling depend on inheritance pattern


Early cochlear implantation and audiologic support are essential in JLN




---


Conclusion


Romano–Ward syndrome and Jervell–Lange-Nielsen syndrome represent two ends of the congenital LQTS spectrum. While both share the same electrophysiological substrate of delayed repolarization, JLN syndrome is distinguished by autosomal recessive inheritance, congenital deafness, and a dramatically higher arrhythmic risk. Early diagnosis, genotype-guided therapy, and family screening remain the cornerstones of improving outcomes in both conditions.


For more cardiology articles and infographics visit:

drmusmanjaved.com



Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...